OncoCyte Property Plant And Equipment Gross vs Cash Analysis

OCX Stock  USD 2.71  0.04  1.50%   
OncoCyte Corp financial indicator trend analysis is much more than just breaking down OncoCyte Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OncoCyte Corp is a good investment. Please check the relationship between OncoCyte Corp Property Plant And Equipment Gross and its Cash accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.

Property Plant And Equipment Gross vs Cash

Property Plant And Equipment Gross vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OncoCyte Corp Property Plant And Equipment Gross account and Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between OncoCyte Corp's Property Plant And Equipment Gross and Cash is 0.75. Overlapping area represents the amount of variation of Property Plant And Equipment Gross that can explain the historical movement of Cash in the same time period over historical financial statements of OncoCyte Corp, assuming nothing else is changed. The correlation between historical values of OncoCyte Corp's Property Plant And Equipment Gross and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Gross of OncoCyte Corp are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Property Plant And Equipment Gross i.e., OncoCyte Corp's Property Plant And Equipment Gross and Cash go up and down completely randomly.

Correlation Coefficient

0.75
Relationship DirectionPositive 
Relationship StrengthSignificant

Property Plant And Equipment Gross

Cash

Cash refers to the most liquid asset of OncoCyte Corp, which is listed under current asset account on OncoCyte Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from OncoCyte Corp customers. The amounts must be unrestricted with restricted cash listed in a different OncoCyte Corp account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from OncoCyte Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OncoCyte Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.At this time, OncoCyte Corp's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 117.1 K in 2024, whereas Discontinued Operations is likely to drop (51.3 M) in 2024.

OncoCyte Corp fundamental ratios Correlations

0.410.910.890.950.91-0.8-0.750.980.860.990.570.080.850.770.68-0.550.95-0.420.980.910.88-0.040.930.80.82
0.410.270.550.520.48-0.06-0.250.270.270.430.510.640.260.280.22-0.240.360.020.320.480.270.580.280.30.41
0.910.270.890.840.92-0.77-0.770.910.80.90.39-0.160.770.770.69-0.670.94-0.480.910.920.82-0.20.870.80.78
0.890.550.890.80.86-0.57-0.670.850.670.910.470.110.660.670.57-0.440.92-0.420.910.860.710.270.840.70.73
0.950.520.840.80.88-0.82-0.680.910.90.930.590.230.890.710.63-0.590.89-0.280.880.880.91-0.10.840.740.79
0.910.480.920.860.88-0.67-0.810.880.750.910.620.00.720.810.73-0.640.9-0.570.881.00.78-0.090.830.840.86
-0.8-0.06-0.77-0.57-0.82-0.670.54-0.85-0.98-0.72-0.240.09-0.97-0.56-0.50.62-0.780.2-0.74-0.67-0.960.44-0.74-0.6-0.56
-0.75-0.25-0.77-0.67-0.68-0.810.54-0.76-0.6-0.77-0.520.35-0.53-1.0-0.990.76-0.660.83-0.76-0.81-0.580.26-0.88-0.99-0.97
0.980.270.910.850.910.88-0.85-0.760.880.960.48-0.060.870.780.69-0.560.94-0.480.980.880.9-0.140.930.80.8
0.860.270.80.670.90.75-0.98-0.60.880.790.350.040.990.630.55-0.660.83-0.210.790.750.99-0.30.780.660.65
0.990.430.90.910.930.91-0.72-0.770.960.790.590.080.780.780.7-0.520.94-0.460.980.910.820.020.930.810.84
0.570.510.390.470.590.62-0.24-0.520.480.350.590.480.370.540.47-0.130.47-0.360.520.620.40.110.530.540.61
0.080.64-0.160.110.230.00.090.35-0.060.040.080.480.11-0.3-0.380.380.050.56-0.010.00.080.56-0.13-0.28-0.16
0.850.260.770.660.890.72-0.97-0.530.870.990.780.370.110.570.48-0.550.84-0.170.780.720.99-0.250.770.60.59
0.770.280.770.670.710.81-0.56-1.00.780.630.780.54-0.30.570.99-0.760.67-0.80.770.810.61-0.250.91.00.98
0.680.220.690.570.630.73-0.5-0.990.690.550.70.47-0.380.480.99-0.770.57-0.820.680.730.52-0.30.840.980.96
-0.55-0.24-0.67-0.44-0.59-0.640.620.76-0.56-0.66-0.52-0.130.38-0.55-0.76-0.77-0.470.45-0.5-0.64-0.560.47-0.61-0.77-0.72
0.950.360.940.920.890.9-0.78-0.660.940.830.940.470.050.840.670.57-0.47-0.390.950.90.88-0.010.870.710.72
-0.420.02-0.48-0.42-0.28-0.570.20.83-0.48-0.21-0.46-0.360.56-0.17-0.8-0.820.45-0.39-0.5-0.57-0.240.18-0.61-0.79-0.74
0.980.320.910.910.880.88-0.74-0.760.980.790.980.52-0.010.780.770.68-0.50.95-0.50.880.820.00.940.790.8
0.910.480.920.860.881.0-0.67-0.810.880.750.910.620.00.720.810.73-0.640.9-0.570.880.78-0.090.830.840.86
0.880.270.820.710.910.78-0.96-0.580.90.990.820.40.080.990.610.52-0.560.88-0.240.820.78-0.240.80.650.64
-0.040.58-0.20.27-0.1-0.090.440.26-0.14-0.30.020.110.56-0.25-0.25-0.30.47-0.010.180.0-0.09-0.24-0.1-0.24-0.16
0.930.280.870.840.840.83-0.74-0.880.930.780.930.53-0.130.770.90.84-0.610.87-0.610.940.830.8-0.10.910.9
0.80.30.80.70.740.84-0.6-0.990.80.660.810.54-0.280.61.00.98-0.770.71-0.790.790.840.65-0.240.910.99
0.820.410.780.730.790.86-0.56-0.970.80.650.840.61-0.160.590.980.96-0.720.72-0.740.80.860.64-0.160.90.99
Click cells to compare fundamentals

OncoCyte Corp Account Relationship Matchups

OncoCyte Corp fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets39.9M55.4M159.6M100.1M74.9M49.1M
Short Long Term Debt Total5.9M8.6M5.7M3.5M2.9M4.1M
Other Current Liab2.6M5.3M9.4M9.2M4.9M4.7M
Total Current Liabilities4.4M9.0M14.1M12.1M7.2M7.6M
Total Stockholder Equity30.8M33.5M65.2M34.3M25.6M22.0M
Property Plant And Equipment Net3.7M6.5M8.5M10.9M5.4M3.8M
Net Debt(16.1M)1.5M(29.9M)(16.4M)(6.6M)(6.9M)
Retained Earnings(93.7M)(123.7M)(187.8M)(260.7M)(289.9M)(275.4M)
Accounts Payable469K432K1.8M1.3M953K621.2K
Cash22.1M7.1M35.6M20.0M9.4M12.8M
Non Current Assets Total16.9M46.2M120.4M74.6M64.2M33.5M
Non Currrent Assets Other2.2M1.9M2.0M2.1M2.2M1.5M
Other Assets2.2M2.1M2.0M1.01.151.09
Cash And Short Term Investments22.5M7.8M36.5M20.4M9.4M14.5M
Common Stock Total Equity124.6M157.2M253.0M294.9M339.2M356.1M
Common Stock Shares Outstanding2.6M3.3M4.4M5.5M7.7M8.0M
Short Term Investments428K379K675K904K433K0.0
Liabilities And Stockholders Equity39.9M55.4M159.6M100.1M74.9M49.1M
Other Current Assets505K1.2M3.9M3.1M782K1.1M
Other Stockholder Equity948K343K37K(5.3M)(4.8M)(4.5M)
Total Liab9.0M21.9M94.3M65.8M49.3M27.1M
Property Plant And Equipment Gross3.7M6.5M8.5M10.9M5.4M3.8M
Total Current Assets23.0M9.2M39.1M25.5M10.7M15.7M
Accumulated Other Comprehensive Income(343K)0.037K39K49K51.5K
Short Term Debt1.4M3.2M3.0M1.6M1.3M1.7M
Common Stock124.6M157.2M253.0M294.9M310.3M325.8M
Property Plant Equipment614K3.7M6.5M8.5M9.8M10.3M
Net Tangible Assets30.8M9.3M(44.7M)(22.0M)(19.8M)(18.8M)
Long Term Debt1.1M347K1.9M1.5M1.7M905.1K
Retained Earnings Total Equity(93.7M)(123.7M)(187.8M)(260.7M)(234.6M)(222.9M)
Long Term Debt Total1.4M534K2.0M1.5M1.7M1.2M
Non Current Liabilities Total4.6M12.9M80.2M53.7M42.1M26.9M
Capital Lease Obligations2.9M4.7M4.4M3.5M2.9M2.8M
Net Invested Capital33.9M37.4M66.5M34.3M20.5M32.0M
Net Working Capital18.5M230K25.0M13.4M3.5M3.3M
Capital Stock124.6M157.2M253.0M294.9M310.3M222.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OncoCyte Stock Analysis

When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.